Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goli Samimi

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|March 3, 2019
Acceptability of Localized Cancer Risk Reduction Interventions Among Individuals at Average or High Risk for CancerGoli Samimi, Brandy M Heckman-Stoddard, Shelley S Kay, et al.
The American Journal of Medicine|December 22, 2019
Cancer Prevention in Primary Care: Perception of Importance, Recognition of Risk Factors and Prescribing BehaviorsGoli Samimi, Brandy M Heckman-Stoddard, Christine Holmberg, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 7, 2020
Assessment of and Interventions for Women at High Risk for Breast or Ovarian Cancer: A Survey of Primary Care PhysiciansGoli Samimi, Brandy M Heckman-Stoddard, Christine Holmberg, et al.
Cancer Medicine|October 30, 2024
Perceptions of Multicancer Detection Tests Among Primary Care Physicians and Laypersons: A Qualitative StudyGoli Samimi, Sarah M Temkin, Carol J Weil, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 14, 2018
Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort StudyBrian Z Ring, Rajmohan Murali, Robert A Soslow, et al.
BMC Genomics|June 16, 2014
Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasmaKristina Warton, Vita Lin, Tina Navin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 3, 2022
Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study DesignsGoli Samimi, Margaret House, Kelly Benante, et al.
Journal of Genetic Counseling|May 26, 2022
Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessmentBita Nehoray, Thomas P Slavin, Can-Lan Sun, et al.
Gynecologic Oncology|November 26, 2011
Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancerCéline Montavon, Brian S Gloss, Kristina Warton, et al.
Iscience|January 5, 2026
High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human diseaseLudmila Szabova, Lucy Lu, Melanie B Gordon, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Cancer Prevention Research (Philadelphia, Pa.)|March 3, 2019
Acceptability of Localized Cancer Risk Reduction Interventions Among Individuals at Average or High Risk for CancerGoli Samimi, Brandy M Heckman-Stoddard, Shelley S Kay, et al.
The American Journal of Medicine|December 22, 2019
Cancer Prevention in Primary Care: Perception of Importance, Recognition of Risk Factors and Prescribing BehaviorsGoli Samimi, Brandy M Heckman-Stoddard, Christine Holmberg, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 7, 2020
Assessment of and Interventions for Women at High Risk for Breast or Ovarian Cancer: A Survey of Primary Care PhysiciansGoli Samimi, Brandy M Heckman-Stoddard, Christine Holmberg, et al.
Cancer Medicine|October 30, 2024
Perceptions of Multicancer Detection Tests Among Primary Care Physicians and Laypersons: A Qualitative StudyGoli Samimi, Sarah M Temkin, Carol J Weil, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 14, 2018
Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort StudyBrian Z Ring, Rajmohan Murali, Robert A Soslow, et al.
BMC Genomics|June 16, 2014
Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasmaKristina Warton, Vita Lin, Tina Navin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 3, 2022
Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study DesignsGoli Samimi, Margaret House, Kelly Benante, et al.
Journal of Genetic Counseling|May 26, 2022
Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessmentBita Nehoray, Thomas P Slavin, Can-Lan Sun, et al.
Gynecologic Oncology|November 26, 2011
Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancerCéline Montavon, Brian S Gloss, Kristina Warton, et al.
Iscience|January 5, 2026
High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human diseaseLudmila Szabova, Lucy Lu, Melanie B Gordon, et al.
Pageof 8